Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
–News Direct–
By Jeremy Golden, Benzinga
Cardiovascular disease is the leading cause of death worldwide, accounting for nearly 18 million deaths annually. That amounts to about one-third of all global deaths. Driven by epigenetics and artificial intelligence, what is being referred to as Precision Cardiovascular Medicine could help alleviate the burden of heart disease on patients worldwide.
Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention and detection more precise, is a potential leader in this developing field of medicine.
AI-Driven
Currently, the risk for cardiovascular disease is assessed using two common lipid-based clinical tests: the Framingham Risk Score and the ASCVD Pool...
